Growth Metrics

Baxter International (BAX) EBIAT (2016 - 2024)

Baxter International (BAX) has disclosed EBIAT for 16 consecutive years, with -$512.0 million as the latest value for Q4 2024.

  • Quarterly EBIAT fell 308.13% to -$512.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$317.0 million through Dec 2024, down 111.42% year-over-year, with the annual reading at -$957.0 million for FY2025, 193.56% down from the prior year.
  • EBIAT for Q4 2024 was -$512.0 million at Baxter International, down from $61.0 million in the prior quarter.
  • The five-year high for EBIAT was $2.5 billion in Q3 2023, with the low at -$3.0 billion in Q3 2022.
  • Average EBIAT over 5 years is $113.7 million, with a median of $205.0 million recorded in 2020.
  • The sharpest move saw EBIAT soared 830.43% in 2020, then tumbled 764.67% in 2022.
  • Over 5 years, EBIAT stood at $168.0 million in 2020, then skyrocketed by 44.05% to $242.0 million in 2021, then crashed by 40.5% to $144.0 million in 2022, then surged by 70.83% to $246.0 million in 2023, then plummeted by 308.13% to -$512.0 million in 2024.
  • According to Business Quant data, EBIAT over the past three periods came in at -$512.0 million, $61.0 million, and $95.0 million for Q4 2024, Q3 2024, and Q2 2024 respectively.